{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T04:07:12Z","timestamp":1790482032653,"version":"4.1.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,8,29]],"date-time":"2017-08-29T00:00:00Z","timestamp":1503964800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,8,29]],"date-time":"2017-08-29T00:00:00Z","timestamp":1503964800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Infiltration of infected leukocytes culminates in establishment of a brain niche for Human Immunodeficiency Virus (HIV) during acute phase of infection, initiating an ongoing cascade of persistent viral replication and inflammation, that causes irreversible neuronal injury and HIV associated neurocognitive disease (HAND). In this study, humanized mice were treated with Smoothened Agonist (SAG), a Sonic Hedgehog (Shh) mimetic in order to fortify blood brain barrier (BBB) and dampen leukocyte extravasation into CNS during AHI. Results indicate that SAG treatment reduced viral burden in the CNS immediately after HIV transmission, but also conferred extended neuroprotection via increased BBB integrity (elevated levels of tight-junction protein, Claudin 5, and reduced S100B levels in periphery). These mice also showed healthier neurons with thick, uniform dendrites and reduced numbers of activated astrocytes. Additional <jats:italic>in vitro<\/jats:italic> experiments suggested SAG treatment was not associated with the establishment or reversal of latency in the target cells. Altogether, these findings validate neuroprotective role of Shh signaling and highlight the therapeutic potential of Shh mimetics against CNS complications associated with HIV infection. Further our results strongly demonstrate that pharmacological interventions to reduce leukocyte mobilization during early HIV infection, can provide prolonged neuroprotection, which might significantly delay the onset of HAND.<\/jats:p>","DOI":"10.1038\/s41598-017-10241-0","type":"journal-article","created":{"date-parts":[[2017,8,21]],"date-time":"2017-08-21T17:23:05Z","timestamp":1503336185000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Sonic Hedgehog mimetic prevents leukocyte infiltration into the CNS during acute HIV infection"],"prefix":"10.1038","volume":"7","author":[{"given":"Vir B.","family":"Singh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meera V.","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorota","family":"Piekna-Przybylska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santhi","family":"Gorantla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larisa Y.","family":"Poluektova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay B.","family":"Maggirwar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,8,29]]},"reference":[{"key":"10241_CR1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2202-5-10","volume":"5","author":"RA Fuller","year":"2004","unstructured":"Fuller, R. A. et al. A prospective longitudinal in vivo 1H MR spectroscopy study of the SIV\/macaque model of neuroAIDS. BMC Neurosci \n                           5, 10, doi:10.1186\/1471-2202-5-10 (2004).","journal-title":"BMC Neurosci"},{"key":"10241_CR2","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1093\/infdis\/jis326","volume":"206","author":"V Valcour","year":"2012","unstructured":"Valcour, V. et al. Central nervous system viral invasion and inflammation during acute HIV infection. J Infect Dis \n                           206, 275\u2013282, doi:10.1093\/infdis\/jis326 (2012).","journal-title":"J Infect Dis"},{"key":"10241_CR3","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1007\/s13365-011-0030-9","volume":"17","author":"MR Lentz","year":"2011","unstructured":"Lentz, M. R. et al. Alterations in brain metabolism during the first year of HIV infection. J Neurovirol \n                           17, 220\u2013229, doi:10.1007\/s13365-011-0030-9 (2011).","journal-title":"J Neurovirol"},{"key":"10241_CR4","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1212\/WNL.0b013e3181a2e90a","volume":"72","author":"MR Lentz","year":"2009","unstructured":"Lentz, M. R. et al. Changes in MRS neuronal markers and T cell phenotypes observed during early HIV infection. Neurology \n                           72, 1465\u20131472, doi:10.1212\/WNL.0b013e3181a2e90a (2009).","journal-title":"Neurology"},{"key":"10241_CR5","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0049272","volume":"7","author":"N Sailasuta","year":"2012","unstructured":"Sailasuta, N. et al. Change in brain magnetic resonance spectroscopy after treatment during acute HIV infection. PLoS One \n                           7, e49272, doi:10.1371\/journal.pone.0049272 (2012).","journal-title":"PLoS One"},{"key":"10241_CR6","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s13365-010-0006-1","volume":"17","author":"RK Heaton","year":"2011","unstructured":"Heaton, R. K. et al. HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors. J Neurovirol \n                           17, 3\u201316, doi:10.1007\/s13365-010-0006-1 (2011).","journal-title":"J Neurovirol"},{"key":"10241_CR7","doi-asserted-by":"publisher","first-page":"2245","DOI":"10.1212\/WNL.43.11.2245","volume":"43","author":"JC McArthur","year":"1993","unstructured":"McArthur, J. C. et al. Dementia in AIDS patients: incidence and risk factors. Multicenter AIDS Cohort Study. Neurology \n                           43, 2245\u20132252 (1993).","journal-title":"Neurology"},{"key":"10241_CR8","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1189\/jlb.0503207","volume":"74","author":"WK Kim","year":"2003","unstructured":"Kim, W. K., Corey, S., Alvarez, X. & Williams, K. Monocyte\/macrophage traffic in HIV and SIV encephalitis. J Leukoc Biol \n                           74, 650\u2013656, doi:10.1189\/jlb.0503207 (2003).","journal-title":"J Leukoc Biol"},{"key":"10241_CR9","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1004533","volume":"10","author":"JH Campbell","year":"2014","unstructured":"Campbell, J. H. et al. Anti-alpha4 antibody treatment blocks virus traffic to the brain and gut early, and stabilizes CNS injury late in infection. PLoS Pathog \n                           10, e1004533, doi:10.1371\/journal.ppat.1004533 (2014).","journal-title":"PLoS Pathog"},{"key":"10241_CR10","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1007\/s11904-014-0255-3","volume":"12","author":"Z Zayyad","year":"2015","unstructured":"Zayyad, Z. & Spudich, S. Neuropathogenesis of HIV: from initial neuroinvasion to HIV-associated neurocognitive disorder (HAND). Curr HIV\/AIDS Rep \n                           12, 16\u201324, doi:10.1007\/s11904-014-0255-3 (2015).","journal-title":"Curr HIV\/AIDS Rep"},{"key":"10241_CR11","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2015.00212","volume":"9","author":"VS Atluri","year":"2015","unstructured":"Atluri, V. S. et al. Effect of human immunodeficiency virus on blood-brain barrier integrity and function: an update. Frontiers in cellular neuroscience \n                           9, 212, doi:10.3389\/fncel.2015.00212 (2015).","journal-title":"Frontiers in cellular neuroscience"},{"key":"10241_CR12","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.brainres.2011.05.015","volume":"1399","author":"M Strazza","year":"2011","unstructured":"Strazza, M., Pirrone, V., Wigdahl, B. & Nonnemacher, M. R. Breaking down the barrier: the effects of HIV-1 on the blood-brain barrier. Brain research \n                           1399, 96\u2013115, doi:10.1016\/j.brainres.2011.05.015 (2011).","journal-title":"Brain research"},{"key":"10241_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/srep26876","volume":"6","author":"VB Singh","year":"2016","unstructured":"Singh, V. B., Singh, M. V., Gorantla, S., Poluektova, L. Y. & Maggirwar, S. B. Smoothened Agonist Reduces Human Immunodeficiency Virus Type-1-Induced Blood-Brain Barrier Breakdown in Humanized Mice. Sci Rep \n                           6, 26876, doi:10.1038\/srep26876 (2016).","journal-title":"Sci Rep"},{"key":"10241_CR14","doi-asserted-by":"publisher","unstructured":"Bambakidis, N. C. et al. Intravenous hedgehog agonist induces proliferation of neural and oligodendrocyte precursors in rodent spinal cord injury. Neurosurgery \n                           67, 1709\u20131715; discussion 1715, doi:10.1227\/NEU.0b013e3181f9b0a5 (2010).","DOI":"10.1227\/NEU.0b013e3181f9b0a5"},{"key":"10241_CR15","doi-asserted-by":"publisher","first-page":"14071","DOI":"10.1073\/pnas.182542899","volume":"99","author":"JK Chen","year":"2002","unstructured":"Chen, J. K., Taipale, J., Young, K. E., Maiti, T. & Beachy, P. A. Small molecule modulation of Smoothened activity. Proc Natl Acad Sci USA \n                           99, 14071\u201314076, doi:10.1073\/pnas.182542899 (2002).","journal-title":"Proc Natl Acad Sci USA"},{"key":"10241_CR16","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3002731","volume":"3","author":"VM Heine","year":"2011","unstructured":"Heine, V. M. et al. A small-molecule smoothened agonist prevents glucocorticoid-induced neonatal cerebellar injury. Sci Transl Med \n                           3, 105ra104, doi:10.1126\/scitranslmed.3002731 (2011).","journal-title":"Sci Transl Med"},{"key":"10241_CR17","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1126\/science.1206936","volume":"334","author":"JI Alvarez","year":"2011","unstructured":"Alvarez, J. I. et al. The Hedgehog pathway promotes blood-brain barrier integrity and CNS immune quiescence. Science \n                           334, 1727\u20131731, doi:10.1126\/science.1206936 (2011).","journal-title":"Science"},{"key":"10241_CR18","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.1212\/01.WNL.0000034177.47015.DA","volume":"59","author":"DB Clifford","year":"2002","unstructured":"Clifford, D. B. et al. A randomized clinical trial of CPI-1189 for HIV-associated cognitive-motor impairment. Neurology \n                           59, 1568\u20131573 (2002).","journal-title":"Neurology"},{"key":"10241_CR19","doi-asserted-by":"publisher","first-page":"1975","DOI":"10.1212\/WNL.0b013e3181c51a48","volume":"73","author":"G Schifitto","year":"2009","unstructured":"Schifitto, G. et al. Selegiline and oxidative stress in HIV-associated cognitive impairment. Neurology \n                           73, 1975\u20131981, doi:10.1212\/WNL.0b013e3181c51a48 (2009).","journal-title":"Neurology"},{"key":"10241_CR20","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1310\/hct1101-59","volume":"11","author":"Y Zhao","year":"2010","unstructured":"Zhao, Y. et al. Memantine for AIDS dementia complex: open-label report of ACTG 301. HIV clinical trials \n                           11, 59\u201367, doi:10.1310\/hct1101-59 (2010).","journal-title":"HIV clinical trials"},{"key":"10241_CR21","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1212\/WNL.0000000000002837","volume":"87","author":"J Hellmuth","year":"2016","unstructured":"Hellmuth, J. et al. Neurologic signs and symptoms frequently manifest in acute HIV infection. Neurology \n                           87, 148\u2013154, doi:10.1212\/WNL.0000000000002837 (2016).","journal-title":"Neurology"},{"key":"10241_CR22","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1004543","volume":"10","author":"A Schuetz","year":"2014","unstructured":"Schuetz, A. et al. Initiation of ART during early acute HIV infection preserves mucosal Th17 function and reverses HIV-related immune activation. PLoS Pathog \n                           10, e1004543, doi:10.1371\/journal.ppat.1004543 (2014).","journal-title":"PLoS Pathog"},{"key":"10241_CR23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0142600","volume":"10","author":"VG Valcour","year":"2015","unstructured":"Valcour, V. G. et al. Neurological Response to cART vs. cART plus Integrase Inhibitor and CCR5 Antagonist Initiated during Acute HIV. PLoS One \n                           10, e0142600, doi:10.1371\/journal.pone.0142600 (2015).","journal-title":"PLoS One"},{"key":"10241_CR24","first-page":"70","volume":"99","author":"NC Bambakidis","year":"2003","unstructured":"Bambakidis, N. C., Wang, R. Z., Franic, L. & Miller, R. H. Sonic hedgehog-induced neural precursor proliferation after adult rodent spinal cord injury. Journal of neurosurgery \n                           99, 70\u201375 (2003).","journal-title":"Journal of neurosurgery"},{"key":"10241_CR25","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1097\/00005373-199912000-00026","volume":"47","author":"C Woertgen","year":"1999","unstructured":"Woertgen, C., Rothoerl, R. D., Metz, C. & Brawanski, A. Comparison of clinical, radiologic, and serum marker as prognostic factors after severe head injury. The Journal of trauma \n                           47, 1126\u20131130 (1999).","journal-title":"The Journal of trauma"},{"key":"10241_CR26","doi-asserted-by":"crossref","first-page":"3142","DOI":"10.1523\/JNEUROSCI.07-10-03142.1987","volume":"7","author":"KS Kosik","year":"1987","unstructured":"Kosik, K. S. & Finch, E. A. MAP2 and tau segregate into dendritic and axonal domains after the elaboration of morphologically distinct neurites: an immunocytochemical study of cultured rat cerebrum. The Journal of neuroscience: the official journal of the Society for Neuroscience \n                           7, 3142\u20133153 (1987).","journal-title":"The Journal of neuroscience: the official journal of the Society for Neuroscience"},{"key":"10241_CR27","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1007\/s13365-013-0218-2","volume":"19","author":"KL Doyle","year":"2013","unstructured":"Doyle, K. L. et al. Real-world impact of neurocognitive deficits in acute and early HIV infection. J Neurovirol \n                           19, 565\u2013573, doi:10.1007\/s13365-013-0218-2 (2013).","journal-title":"J Neurovirol"},{"key":"10241_CR28","doi-asserted-by":"publisher","first-page":"11708","DOI":"10.1128\/JVI.77.21.11708-11717.2003","volume":"77","author":"M Guadalupe","year":"2003","unstructured":"Guadalupe, M. et al. Severe CD4+ T-cell depletion in gut lymphoid tissue during primary human immunodeficiency virus type 1 infection and substantial delay in restoration following highly active antiretroviral therapy. J Virol \n                           77, 11708\u201311717 (2003).","journal-title":"J Virol"},{"key":"10241_CR29","first-page":"146","volume":"20","author":"F Gray","year":"2001","unstructured":"Gray, F. et al. Neuropathology and neurodegeneration in human immunodeficiency virus infection. Pathogenesis of HIV-induced lesions of the brain, correlations with HIV-associated disorders and modifications according to treatments. Clin Neuropathol \n                           20, 146\u2013155 (2001).","journal-title":"Clin Neuropathol"},{"key":"10241_CR30","doi-asserted-by":"publisher","first-page":"8869","DOI":"10.1073\/pnas.95.15.8869","volume":"95","author":"TW Chun","year":"1998","unstructured":"Chun, T. W. et al. Early establishment of a pool of latently infected, resting CD4(+) T cells during primary HIV-1 infection. Proc Natl Acad Sci USA \n                           95, 8869\u20138873 (1998).","journal-title":"Proc Natl Acad Sci USA"},{"key":"10241_CR31","doi-asserted-by":"publisher","first-page":"3148","DOI":"10.1523\/JNEUROSCI.5473-10.2011","volume":"31","author":"PK Dash","year":"2011","unstructured":"Dash, P. K. et al. Loss of neuronal integrity during progressive HIV-1 infection of humanized mice. The Journal of neuroscience: the official journal of the Society for Neuroscience \n                           31, 3148\u20133157, doi:10.1523\/JNEUROSCI.5473-10.2011 (2011).","journal-title":"The Journal of neuroscience: the official journal of the Society for Neuroscience"},{"key":"10241_CR32","doi-asserted-by":"publisher","DOI":"10.1186\/2040-7378-4-20","volume":"4","author":"K Moller","year":"2012","unstructured":"Moller, K., Stahl, T., Boltze, J. & Wagner, D. C. Isolation of inflammatory cells from rat brain tissue after stroke. Experimental & translational stroke medicine \n                           4, 20, doi:10.1186\/2040-7378-4-20 (2012).","journal-title":"Experimental & translational stroke medicine"},{"key":"10241_CR33","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1016\/j.celrep.2017.01.022","volume":"18","author":"A Bosque","year":"2017","unstructured":"Bosque, A. et al. Benzotriazoles Reactivate Latent HIV-1 through Inactivation of STAT5 SUMOylation. Cell Rep \n                           18, 1324\u20131334, doi:10.1016\/j.celrep.2017.01.022 (2017).","journal-title":"Cell Rep"},{"key":"10241_CR34","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1080\/15384101.2017.1312225","volume":"16","author":"D Piekna-Przybylska","year":"2017","unstructured":"Piekna-Przybylska, D., Sharma, G., Maggirwar, S. B. & Bambara, R. A. Deficiency in DNA damage response, a new characteristic of cells infected with latent HIV-1. Cell Cycle \n                           16, 968\u2013978, doi:10.1080\/15384101.2017.1312225 (2017).","journal-title":"Cell Cycle"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-10241-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-10241-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-10241-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T09:39:37Z","timestamp":1671788377000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-10241-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,29]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,12]]}},"alternative-id":["10241"],"URL":"https:\/\/doi.org\/10.1038\/s41598-017-10241-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,29]]},"assertion":[{"value":"8 May 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"9578"}}